Management maintained its full-year guidance for $4 billion to $4.05 billion in revenue. DexCom experienced slower growth and profitability challenges, but still met management's expectations for ...
Over the past five years, diabetes-focused medical device specialist DexCom (NASDAQ: DXCM) has made meaningful progress on several fronts. The company launched new products in the continuous ...
Ladies and gentlemen, welcome to the DexCom Third Quarter 2024 Earnings ... on all stages of the product experience, everything from ordering through our e-commerce platform, the speed of delivery ...
With a market cap of $27.1 billion, DexCom, Inc. (DXCM) is a leading medical device company, specializing in continuous glucose monitoring (CGM) systems for diabetes management. The San Diego ...
In this article, we are going to take a look at where DexCom, Inc. (NASDAQ ... We listed the stocks in descending order of their hedge fund sentiment as of the second quarter, which was taken ...
SAN DIEGO (AP) — SAN DIEGO (AP) — DexCom Inc. (DXCM) on Thursday reported third-quarter earnings of $134.6 million. The San Diego-based company said it had net income of 34 cents per share.